Quick Answer
Instil Bio, Inc. reported R&D Expense of $39.60 million for fiscal year 2023.
Instil Bio, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2023 | $39.60M | -71.9% |
| 2022 | $141.06M | +31.5% |
| 2021 | $107.25M | +452.9% |
| 2020 | $19.40M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | $2.92M | -65.5% | -59.7% |
| March 31, 2024 | $7.26M | -64.9% | -14.6% |
| September 30, 2023 | $8.49M | -78.6% | +0.4% |
| June 30, 2023 | $8.46M | -79.6% | -59.1% |
| March 31, 2023 | $20.67M | -47.2% | -47.9% |
| September 30, 2022 | $39.66M | +36.5% | -4.4% |
| June 30, 2022 | $41.50M | +95.9% | +5.9% |
| March 31, 2022 | $39.17M | +171.6% | +34.8% |
- Instil Bio, Inc. showed a decrease of -71.9% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2023 period, Instil Bio, Inc.’s r&d expense has grown by 104.2% (from $19.40 million to $39.60 million).
- The most recent figure is from Instil Bio, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 21, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: